Semaglutide and pregnancy don't mix: FDA labels say stop the drug at least 2 months before conceiving. Here's what the research and doctors say.
Semaglutide is not recommended during pregnancy. The FDA labels for Ozempic, Wegovy, and Rybelsus all advise stopping the medication at least two months before you plan to conceive, and no version of the drug is approved for use in pregnant people. If you are pregnant and currently taking semaglutide, contact your healthcare provider right away — but try not to panic, because the available human data do not prove that the drug causes birth defects.
Can You Take Semaglutide While Pregnant?
No. Semaglutide has not been studied in adequate, well-controlled trials of pregnant women, and regulators have concluded that the potential risks outweigh any expected benefit during pregnancy. That guidance applies to every form of the drug: the weekly injections sold as Ozempic and Wegovy, and the daily oral tablet sold as Rybelsus.
Semaglutide works by mimicking GLP-1, a hormone that slows stomach emptying, increases insulin release, and reduces appetite. Those effects are useful for type 2 diabetes and chronic weight management, but rapid weight loss during pregnancy is generally discouraged, and a developing fetus has no need for appetite suppression.
If you are already pregnant, do not start semaglutide, and do not stop a prescribed medication without talking to your clinician first. Blood sugar control in pregnancy matters, so your care team will want to adjust your treatment plan rather than leave it unmanaged.
What the FDA Labels Say About Semaglutide and Pregnancy
The prescribing information for each semaglutide product gives specific pregnancy guidance. The wording differs slightly by product, but the theme is consistent.
| Product | Main approved use | Pregnancy guidance on the label |
|---|---|---|
| Ozempic (injectable semaglutide) | Type 2 diabetes | Discontinue at least 2 months before a planned pregnancy; not recommended in pregnancy |
| Wegovy (injectable semaglutide) | Chronic weight management | Discontinue at least 2 months before a planned pregnancy; not recommended in pregnancy |
| Rybelsus (oral semaglutide) | Type 2 diabetes | Discontinue at least 2 months before a planned pregnancy; use only if the potential benefit justifies the potential risk |
The two-month window exists because semaglutide clears slowly from the body. Injectable semaglutide has a half-life of about one week, so it takes roughly a month for most of the drug to leave your system — the label adds a buffer on top of that.
What the Research Actually Shows
Animal studies are the main source of concern. In rats and rabbits given semaglutide during organ development, researchers observed increased rates of skeletal abnormalities, reduced fetal weight, and pregnancy loss — generally at doses high enough to cause significant maternal weight loss.
Human data remain thin. There is no large randomized trial of semaglutide in pregnancy, so researchers rely on pregnancy exposure registries, insurance claims databases, and case reports. Those sources have not shown a clear, consistent pattern of major birth defects, but the numbers are too small to rule out a modest increase in risk.
Semaglutide is not FDA-approved for use during pregnancy, and the absence of a confirmed safety signal in limited human data is not the same as proven safety.
Why Weight Loss Can Lead to Surprise Pregnancies
Many people start semaglutide for weight loss and conceive sooner than expected. Losing weight can restore ovulation in people with obesity-related infertility or polycystic ovary syndrome, and improved insulin sensitivity can support fertility as well.
Because semaglutide can restore ovulation, unintended pregnancy is a real possibility during treatment, especially if your cycles have been irregular. Providers typically recommend reliable contraception while using semaglutide if pregnancy is not desired.
Online forums are full of anecdotes — browsing semaglutide and menstrual cycle reddit threads turns up plenty of stories about changed periods and surprise positive tests. Those stories are not evidence, but they do reflect a pattern worth raising with your doctor.
If You're Pregnant and Taking Semaglutide
- Stop the medication and call your provider. Most clinicians advise discontinuing semaglutide as soon as pregnancy is confirmed.
- Ask about blood sugar monitoring. If you have type 2 diabetes, you will need a replacement plan, often insulin.
- Mention it before any surgery or procedure. GLP-1 drugs slow gastric emptying, which matters for anesthesia.
- Keep the rest of your routine simple. Skip alcohol — semaglutide and alcohol together can worsen nausea and dehydration, and no amount of alcohol is considered safe in pregnancy.
Safer Options During Pregnancy
For gestational diabetes, insulin is the standard first-line treatment because it has decades of safety data in pregnancy. Metformin is sometimes used, but it crosses the placenta and is generally a second choice.
For weight management, structured nutrition counseling and appropriate physical activity are the recommended approach. Weight-loss medications — including semaglutide, tirzepatide, and investigational compounds — are not part of routine pregnancy care.
The same caution extends to research peptides. Questions about retatrutide and pregnancy get the same answer as semaglutide: no human safety data and no recommendation for use while pregnant or breastfeeding. Other wellness injections deserve equal scrutiny, and glutathione and pregnancy is another pairing where human safety data are limited and clinician guidance should come first.
Breastfeeding and Future Pregnancies
Semaglutide is present in the milk of lactating animals, and there are no human milk data. The label does not recommend semaglutide during breastfeeding.
If you want to restart semaglutide after giving birth, plan the timing with your provider, particularly if you are breastfeeding or hoping to conceive again soon. Many people track their progress with semaglutide before and after photos, but the clinical priority after delivery is recovery, nutrition, and blood sugar control.
Talking to Your Healthcare Provider
Bring a short list to your appointment: your dose, your last injection date, your pregnancy test date, and any other medications or supplements you take. Your clinician can then decide whether you need early monitoring, a diabetes medication switch, or a referral to a high-risk obstetrician.
Nothing here replaces personalized medical advice. Pregnancy is a time when individual risk factors — diabetes, blood pressure, prior pregnancy history — matter far more than general guidance.
Frequently Asked Questions
Can you take semaglutide while pregnant?
No. Semaglutide is not recommended at any point during pregnancy, and the FDA labels for Ozempic, Wegovy, and Rybelsus all advise stopping the drug at least two months before a planned pregnancy. If you become pregnant while taking semaglutide, contact your healthcare provider to discuss stopping it and adjusting your treatment plan.
How long before trying to conceive should I stop semaglutide?
The FDA labels recommend stopping semaglutide at least two months before a planned pregnancy. Semaglutide has a half-life of about one week, so most of the drug clears your system in roughly a month; the two-month window adds a safety buffer. Your provider may adjust the timeline based on your dose and health history.
Does semaglutide cause birth defects?
Animal studies showed fetal harm, including skeletal abnormalities and reduced fetal weight, at doses high enough to cause maternal weight loss. Human data are limited, and registry and observational data have not confirmed a clear increase in major birth defects. Because the evidence is incomplete, semaglutide is not considered safe in pregnancy.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.